Sorry to report -- but, Here we go again!
August 17, 2015 ..."Novartis has been informed of a third case of progressive multifocal leukoencephalopathy (PML) in a patient with relapsing MS (RMS) treated with Gilenya without prior exposure to natalizumab treatment. "
https://www.novartis.com/news/statements/gilenya-information-center

Novartis has been informed of a third case of progressive multifocal leukoencephalopathy (PML) in a patient with relapsing MS (RMS) treated with Gilenya without prior exposure to natalizumab treatment. The patient also has a history of colorectal cancer treated with chemotherapy and radiation treatm…